Insulin Pumps Shown To Improve Type 2 Diabetes Management

Insulin Pumps Shown To Improve Type 2 Diabetes Management - Medtronic 640G

Medtronic Inc. has announced the publication of new data in Diabetes, Obesity and Metabolism from the continuation phase of the OpT2mise study, providing further clinical evidence in support of insulin pumps for people with insulin-requiring type 2 diabetes. The OpT2mise … Read more

LifeScan Introduces New OneTouch Verio Flex Glucometer

OneTouch Vario Flex

LifeScan has introduced the new OneTouch Verio Flex blood glucose monitoring system, with ColorSure technology – a simple, accurate and easy-to-use meter that takes the guesswork out of understanding blood sugar test results for people with diabetes.  Its simple color … Read more

FDA Approves Animas Vibe and CGM for Children

Animas Vibe

The U.S. FDA has approved Animas Vibe Insulin Pump and Continuous Glucose Monitoring (CGM) System for management of diabetes in children and adolescents, ages 2 to 17. The Animas Vibe System was the first integrated system with Dexcom G4 PLATINUM … Read more

FDA Revises Labels of SGLT2 Inhibitors

FDA large logo

A U.S. FDA safety review has resulted in adding warnings to the labels of a specific class of type 2 diabetes medicines called sodium-glucose cotransporter-2 (SGLT2) inhibitors (such as Invokana, Farxiga and Jardiance) about the risks of too much acid in the blood and of serious urinary tract infections. Both conditions can result in hospitalization. Read more

Medtronic Discontinues The Sof-sensor CGM Sensor


Medtronic has announced that it will no longer sell its CGM Sof-sensor as of Dec. 1, 2015. Medtronic is offering no out of pocket cost conversion programs to their latest insulin pump and CGM technology, the MiniMed 530G with Enlite. Read more

FDA Approval for Tresiba and Ryzodeg, Long Lasting Insulin Drugs

Novo_Nordisk large

More than two years after dealing Novo Nordisk a surprising setback, the U.S. Food and Drug Administration has approved Tresiba (insulin degludec injection) and Ryzodeg 70/30 (insulin degludec/insulin aspart injection) to improve blood sugar control in adults with diabetes mellitus. … Read more

Subscribe to our Newsletter

Hide me